Internal Medicine, Hematology & Oncology · Chapel Hill, NC
NPI
1265688493
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
170 Manning Dr, Cb 7305
Chapel Hill, NC, 27514
Phone (909) 966-4431
Groups this clinician bills Medicare through
Medicare paid, 2024
$15K
226 services
Medicare patients, 2024
114
Average age 74
Drug cost, 2024
$3.9M
438 prescriptions
Company payments, 2025
$44K
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brandi N Reeves was code 99215 (office e&m - established), 77 times for 60 patients. In total Brandi N Reeves billed 226 services in 12 codes, and Medicare paid $15K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-04-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 77 | 60 | $92.35 | $7,111 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 61 | 52 | $11.72 | $715 |
| 99214 Office E&M - Established | Facility | 25 | 22 | $68.47 | $1,712 |
| 99223 Hospital E&M - Initial | Facility | 14 | 14 | $127.70 | $1,788 |
| 99205 Office E&M - New | Facility | 13 | 13 | $114.70 | $1,491 |
By year: 2022 $14K for 183 services; 2023 $18K for 196 services; 2024 $15K for 226 services.
Medicare prescription drug claims, 2024
In 2024, the drug Brandi N Reeves prescribed most often to Medicare patients was Hydroxyurea, with 98 prescriptions and refills. In total Brandi N Reeves wrote 438 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxyurea Generic | 98 | 246 | 33 | $3,610 |
| Jakafi Ruxolitinib Phosphate | 59 | 59 | Under 11 | $1.1M |
| Besremi Ropeginterferon Alfa-2b-Njft | 53 | 53 | 14 | $766K |
| Pegasys Peginterferon Alfa-2a | 46 | 46 | Under 11 | $94K |
| Ojjaara Momelotinib Dihydrochloride | 37 | 37 | Under 11 | $971K |
| Vonjo Pacritinib Citrate | 31 | 31 | Under 11 | $764K |
| Cyclosporine Modified Cyclosporine, Modified | 24 | 24 | Under 11 | $1,932 |
Brand drugs: 246 claims; generic drugs: 192 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brandi N Reeves $44K ($44K in general payments such as food, travel and fees) from 7 companies. The largest payer was Incyte Corporation with $22K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.